AAAfrouz Abbaspour

Afrouz Abbaspour

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Afrouz Abbaspour has a total of 65 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Characteristics of Monozygotic Twins Discordant for Anorexia Nervosa: Comprehensive Risk Evaluation for Anorexia Nervosa in Twins (CREAT) Study

    by Hunna J. Watson, Elisabeth Welch, Elin Monell, Emma Forsén Mantilla, Lisa Dinkler, Johanna Levallius, Lauren Breithaupt, Camilla A. Wiklund, Afrouz Abbaspour, Christopher Hübel, et al.

    Objective: To characterise the clinical and phenotypic profile of the Comprehensive Risk Evaluation for Anorexia nervosa in Twins (CREAT) cohort, identify candidate risk and illness‐related correlates of AN, and establish a foundation for forthcoming biological, neuroimaging, endocrinological, and microbiota studies. Methods: MZ twins discordant for lifetime AN (44 individuals) and control MZ twin pairs (42 individuals) were recruited. Analyses included total‐sample associations with AN, between‐group comparisons (affected, unaffected co‐twins, controls), and within‐pair analyses of discordant twins. Results: Affected twins, most of whom were weight‐restored and non‐acute, differed markedly from unaffected co‐twins and controls. Lifetime AN was associated with higher perfectionism, goal‐directed drive, neuroticism, behavioural inhibition, impulsivity, broader psychiatric symptoms, teasing history, autism symptoms, and lower quality of life. Within‐pair analyses implicated perfectionism, goal‐directed drive, and competency‐related teasing as candidate individual‐specific risk factors for AN, with evidence of additional associations with impulsivity, behavioural inhibition, neuroticism, broader psychiatric symptoms, and autism symptoms. Conclusion: Findings support a multifactorial model of AN involving individual‐specific influences and shared familial liability. Perfectionism, goal‐directed drive, and competency‐related teasing emerged as candidate individual‐specific risk factors, while the pattern of elevations, with unaffected co‐twins often falling between affected twins and healthy controls, suggests that several clinical and phenotypic features may reflect familial liability for AN.

  • Open Access

    Maladaptive Exercise in People With a Lifetime History of Eating Disorders: A Multicountry Observational Study

    by Hunna J. Watson, Katherine Schaumberg, Laura M. Thornton, Hannah L. Kennedy, Shu H. Ong, Preston Roche, Wesley R. Barnhart, Sian B. Pauley‐Gadd, Kayla Costello, Rachael E. Flatt, et al.

    Objective: Maladaptive exercise (ME), problematic attitudes or behaviors related to physical activity, is often observed in eating disorders (EDs), but its prevalence, severity, and relationships with ED features remain incompletely characterized. This study aimed to describe lifetime and current ME across ED diagnoses, examine associations with ED symptoms, sociodemographic characteristics, and weight status, and compare ME phenotypes to identify those most strongly linked to ED features. Methods: ME was assessed in 31,671 individuals with lifetime EDs (anorexia nervosa [AN], bulimia nervosa, and binge‐eating disorder [BED]) recruited to sites in the United States, Australia, New Zealand, and Sweden as part of the Eating Disorders Genetics Initiative ( NCT04378101 ). We examined one lifetime ME phenotype, capturing any occurrence of ME across the lifespan (derived from the ED100K), and five current ME phenotypes (any driven exercise [Eating Disorder Examination‐Questionnaire, EDE‐Q], frequency of driven exercise [EDE‐Q], regular driven exercise [EDE‐Q], compulsive exercise test [CET] total, and dichotomous compulsive exercise [CET]). Results: Lifetime ME was highly prevalent across countries and ED diagnoses (pooled prevalence 88%). Current ME was also common (40% any driven exercise, 35% compulsive exercise, and 12% regular driven exercise), highest in AN and lowest, but notable, in BED. CET‐based phenotypes showed the strongest association with ED symptoms, while EDE‐Q‐derived regular driven exercise was most strongly associated with underweight (BMI < 18.5). Younger generations exhibited a higher ME risk, likely reflecting societal shifts in body ideals and fitness culture. Discussion: This large, multicountry study demonstrates that ME is highly prevalent across EDs, often emerges early, and can persist or recur for decades. Prevalence and severity vary considerably by assessment method. The ED100K, CET, and EDE‐Q capture complementary aspects of ME, and incorporating all three may improve clinical care. We recommend that clinicians assess both current and lifetime ME in all patients with EDs. Routine, harmonized assessment will be essential to advancing research and improving patient outcomes. Trial Registration: ClinicalTrials.gov identifier: NCT04378101


  • Open Access

    A Method for Comparing Proteins Measured in Serum and Plasma by Olink Proximity Extension Assay

    by Rawan Shraim, Caroline Diorio, Scott W. Canna, Erin Macdonald-Dunlop, Hamid Bassiri, Zachary Martinez, Anders Mälarstig, Afrouz Abbaspour, David T. Teachey, Robert B. Lindell, et al.


  • Open Access

    ARFID InitiativE Sweden (ARIES): study protocol for a large-scale genetic and registry-linked cohort study on avoidant/restrictive food intake disorder

    by Liv Hog, Bengt T Fundin, Erik Everett Palm, Annelie Billger, Cynthia M Bulik, Afrouz Abbaspour, Lisa Dinkler

    Introduction The ARFID InitiativE Sweden (ARIES) investigates the genetic and environmental factors contributing to avoidant/restrictive food intake disorder (ARFID) in children and adolescents aged 6–14 years. ARIES will establish a national biobank and research registry. It aims to provide data for immediate research and track ARFID outcomes and clarify genetic links between ARFID and other conditions and analyse the gut microbiome to guide nutrition interventions. Methods and analysis The study will involve 1500 Swedish children and adolescents with ARFID and a control group of 500 Swedish children and adolescents without ARFID. Parents/guardians and their children will complete online questionnaires assessing ARFID and other eating disorder (ED) pathology, co-occurring conditions, quality of life and parental stress and ED pathology. All participants will provide a saliva sample for comprehensive genetic analyses. Additionally, a subset of participants will provide a stool sample to investigate the gut microbiome in ARFID. Ethics and dissemination ARIES was approved by the Swedish Ethical Review Authority (Dnr 2023-04638). All participants will give assent and their parents will complete informed consent. Data will be made available by the authors on reasonable request. Findings will be published in scientific journals and shared with the public and stakeholders in accessible ways, for example, via social media.


  • Open Access

    Assessing Avoidant/Restrictive Food Intake Disorder (ARFID) Symptoms Using the Nine Item ARFID Screen in >9000 Swedish Adults With and Without Eating Disorders

    by Emily K. Presseller, Gabrielle E. Cooper, Laura M. Thornton, Andreas Birgegård, Afrouz Abbaspour, Cynthia M. Bulik, Emma Forsén Mantilla, Lisa Dinkler

    Objective: The Nine Item ARFID Scale (NIAS) is a widely used measure assessing symptoms of avoidant/restrictive food intake disorder (ARFID). Previous studies suggest that individuals with eating disorders driven by shape/weight concerns also have elevated scores on the NIAS. To further describe NIAS scores among individuals with diverse current and previous eating disorders, we characterized NIAS scores in a large sample of individuals with eating disorders and evaluated overlap in symptoms measured by the NIAS and the Eating Disorder Examination‐Questionnaire (EDE‐Q) version 6.0.Method: Our sample comprised 9148 participants from the Eating Disorders Genetics Initiative Sweden (EDGI‐SE), who completed surveys including NIAS and EDE‐Q. NIAS scores were calculated and compared by eating disorder diagnostic group using descriptive statistics and linear models.Results: Participants with current anorexia nervosa demonstrated the highest mean NIAS scores and had the greatest proportion (57.0%) of individuals scoring above a clinical cutoff on at least one of the NIAS subscales. Individuals with bulimia nervosa, binge‐eating disorder, and other specified feeding or eating disorder also demonstrated elevated NIAS scores compared to individuals with no lifetime history of an eating disorder (ps < 0.05). All subscales of the NIAS showed small to moderate correlations with all subscales of the EDE‐Q (rs = 0.26–0.40).Discussion: Our results substantiate that individuals with eating disorders other than ARFID demonstrate elevated scores on the NIAS, suggesting that this tool is inadequate on its own for differentiating ARFID from shape/weight‐motivated eating disorders. Further research is needed to inform clinical interventions addressing the co‐occurrence of ARFID‐related drivers and shape/weight‐related motivation for dietary restriction.


  • Open Access

    Challenges and priorities for researching the gut microbiota in individuals living with anorexia nervosa

    by Madeline L. West, Susan Hart, Amy Loughman, Felice N. Jacka, Heidi M. Staudacher, Afrouz Abbaspour, Andrea Phillipou, Anu Ruusunen, Tetyana Rocks

    Objective: The gut microbiota is implicated in several symptoms and biological pathways relevant to anorexia nervosa (AN). Investigations into the role of the gut microbiota in AN are growing, with a specific interest in the changes that occur in response to treatment. Findings suggest that microbial species may be associated with some of the symptoms common in AN, such as depression and gastrointestinal disturbances (GID). Therefore, researchers believe the gut microbiota may have therapeutic relevance. Whilst research in this field is rapidly expanding, the unique considerations relevant to conducting gut microbiota research in individuals with AN must be addressed.Method: We provide an overview of the published literature investigating the relationship between the gut microbiota and symptoms and behaviors present in AN, discuss important challenges in gut microbiota research, and offer recommendations for addressing these. We conclude by summarizing research design priorities for the field to move forward.Results: Several ways exist to reduce participant burden and accommodate challenges when researching the gut microbiota in individuals with AN.Discussion: Recommendations from this article are foreseen to encourage scientific rigor and thoughtful protocol planning for microbiota research in AN, including ways to reduce participant burden. Employing such methods will contribute to a better understanding of the role of the gut microbiota in AN pathophysiology and treatment.Public Significance: The field of gut microbiota research is rapidly expanding, including the role of the gut microbiota in anorexia nervosa. Thoughtful planning of future research will ensure appropriate data collection for meaningful interpretation while providing a positive experience for the participant. We present current challenges, recommendations for research design and priorities to facilitate the advancement of research in this field.